Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05867433
Other study ID # IRB2022-1159D
Secondary ID R01MD018214
Status Recruiting
Phase N/A
First received
Last updated
Start date September 27, 2023
Est. completion date April 15, 2027

Study information

Verified date April 2024
Source Texas A&M University
Contact Jacob S Szeszulski, PhD
Phone 972-231-5362
Email jacob.szeszulski@ag.tamu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Strong Teens for Healthy Schools (STHS) is a school-based, civic engagement program that empowers middle school students to improve their physical activity and healthy eating behaviors, improve their cardiovascular disease outcomes, and create positive change in their school health environments.


Description:

The investigators will conduct a cluster-randomized controlled trial to evaluate the impact of the Strong Teens for Healthy Schools (STHS) program on cardiovascular disease-related outcomes. STHS is a multi-level, theory-based civic engagement program to catalyze positive food and physical activity environmental change and improve cardiovascular disease-related health (CVD) outcomes among 6th and 7th-grade students. Title 1 middle schools in Texas (n=20) with > 40% Hispanic and Black students will be randomized at baseline to the intervention condition (STHS program) or control condition (will continue with usual care, as they will not be asked to add or remove any of their current, physical activity, healthy eating, or positive youth development programming) (n=20-25 students per school). The investigators hypothesize that students who participate in STHS will have reduced MetS risk, improved positive youth developmental outcomes, and improved social and environmental outcomes immediately post-intervention and one year after study completion compared to students in a control condition.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date April 15, 2027
Est. primary completion date April 15, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years and older
Eligibility School Inclusion Criteria: - > 50 6th and 7th grade students - > 40% economically disadvantaged students - > 40% Black and Hispanic students School Exclusion Criteria: Student Inclusion Criteria: - 6th or 7th grade student - Attend a Title 1 middle school that is participating in the STHS intervention - Read and understand English Student Exclusion Criteria: - Participation in a weight loss program in the past 3 months - Presence of a condition that prevents participation in physical activity

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
STHS Intervention
STHS program The intervention group (10 schools) will participate in the STHS program. During the fall semester (September to December), the intervention group will receive 24 thirty-minute modules (or twelve 1-hour modules) that provide education on civic engagement, healthy eating, and physical activity. During the spring semester (February to May), the intervention group will receive 24 thirty-minute modules (or twelve 1-hour modules) that focus on implementing the school health environmental change project and receive support for maintaining individual-level healthy eating and physical activity behaviors.
Usual Care
No STHS program The usual care group will be offered the same activities as the intervention group after the conclusion of the research study.

Locations

Country Name City State
United States Texas A&M AgriLife Dallas Center Dallas Texas

Sponsors (2)

Lead Sponsor Collaborator
Texas A&M University National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence or absence of metabolic syndrome (MetS) MetS is present after identifying abdominal obesity plus at least two of the four other MetS Risk factors: high blood pressure, high blood sugar, low HDL cholesterol, and high triglyceride levels.
MetS = (abdominal obesity) + (2 of 4 other MetS Risk factors)
Measures to determine MetS risk factors:
Abdominal obesity: waist circumference >90th percentile for child's sex and age
High blood pressure: systolic blood pressure =130 mm Hg or diastolic blood pressure =90 mmHg)
High blood glucose: blood glucose =5.6 mmol/L or known diabetes
Low HDL cholesterol: HDL cholesterol <1.03 mmol/L
High triglyceride level: Triglyceride level = 1.7mmol/L
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Primary Change in the number of MetS risk factors Change in the number of MetS risk factors = (new # of MetS risk factors) - (original # of MetS risk factors)
Measures to determine MetS risk factors:
Abdominal obesity: waist circumference >90th percentile for child's sex and age
High blood pressure: systolic blood pressure =130 mm Hg or diastolic blood pressure =90 mmHg)
High blood glucose: blood glucose =5.6 mmol/L or known diabetes
Low HDL cholesterol: HDL cholesterol <1.03 mmol/L
High triglyceride level: Triglyceride level = 1.7mmol/L
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Primary Positive Youth Development score Positive youth development will be measured using a 5 C's Model of Positive Youth Development Scale-Short Form (PYD-SF): A 34-item scale that assesses the strength of psychological, behavioral, and social development in youth.
The five dimensions measured are:
Competence (sense of proficiency)
Confidence (self-worth, self-efficacy)
Character (adherence to societal and cultural rules)
Connection (bonds with people and institutions)
Caring (sympathy and empathy towards others)
Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Blood pressure level Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Concentration of blood glucose Glucose will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Waist circumference Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Concentration of HDL cholesterol HDL-C will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Concentration of serum triglycerides Triglycerides will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Height Height will be measured using a stadiometer in inches. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Weight Weight will be measured with a scale in pounds. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Body mass index (BMI) Weight will be measured with a scale, and height will be measured using a stadiometer. BMI will be calculated as BMI = (weight (lb)/height (inches)2) x 703. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Concentration of subdermal carotenoids The concentration of subdermal carotenoids will assess the changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary Accelerometer-derived physical activity estimation Physical activity will be measured using Actigraph accelerometers. Measurements will include light physical activity (PA), moderate PA, moderate to vigorous PA, and vigorous PA. Baseline to 9 months
Secondary Sedentary time Sedentary time will be measured using Actigraph accelerometers. Baseline to 9 months
Secondary Time spent sleeping Sleep time will be measured using Actigraph accelerometers. Baseline to 9 months
Secondary Physical fitness capacity estimation Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness. Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention
Secondary School physical activity and nutrition environment assessment The school's physical activity and nutrition environments will be measured using a self-reported School Environment Survey. Baseline to 9 months
Secondary Assessment of perceptions of school environments and school-specific dietary intake patterns Perceptions related to physical activity and nutrition within the school setting will be measured using the Perceptions of the Environment and Patterns of Diet at School (PEA-PODS) survey. Baseline to 9 months
Secondary Assessment of perceived sociopolitical control Perceived sociopolitical control will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' perceived sociopolitical control (i.e., participation in advocacy programs and optimism for change). Baseline to 9 months
Secondary Assessment of assertiveness Assertiveness will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' assertiveness (i.e., ability to engage with adults and peers). Baseline to 9 months
Secondary Assessment of participatory competence and decision-making Participatory competence and decision-making will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' participatory competence and decision-making (i.e., ability to influence group decision-making). Baseline to 9 months
Secondary Assessment of advocacy outcome efficacy Advocacy outcome efficacy will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' advocacy outcome efficacy (i.e., belief in their ability to work with others to improve the school's physical activity and nutrition environment). Baseline to 9 months
Secondary Peer concentration of subdermal carotenoids The concentration of subdermal carotenoids will assess peers' engagement in health behaviors changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy. Baseline to 9 months
Secondary Peer Body mass index (BMI) Peers' engagement in health behaviors will be measured by the change in peers' BMI. Weight will be measured with a scale, and height will be measured using a stadiometer. Calculate BMI with the formula: BMI = (weight (lb)/height (inches)2) x 703. Baseline to 9 months
Secondary Peer physical fitness capacity estimation Peers' engagement in health behaviors will be measured by the change in peers' physical fitness. Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness. Baseline to 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)